Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Andreas C Petropoulos

Andreas C Petropoulos

Azerbaijan State Medical University
Azerbaijan

Title: Options in managing Heart Failure in Pediatrics. What is new in the 2014 ISHLT guidelines

Biography

Biography: Andreas C Petropoulos

Abstract

Heart failure (HF) is childhood is a clinical and pathophysiological syndrome resulting from: 1. Ventricular inotropic dysfunction, 2. Volume and/or Pressure overload, 3. Irregular heart rhythm 4. Long standing Hyper dynamic Circulations. It presents as failure to thrive, respiratory distress, exercise intolerance and associated with circulatory, neurohormonal, molecular abnormalities. HF has numerous etiologies. It is a common clinical presentation as a consequence of cardiac or non-cardiac disorders, congenital or acquired. Worldwide prevalence is 322cases/million /children. From these 43% are under the age of 1 year old. In the CHD population 24% will present with HF and 70% will suffer from it in the 1st year following the diagnosis of CHD. At diagnosis 71% of DCM ‘s and 13% HOCM’s will present with HF. The aim of this paper is to present the current advances on evaluation and management of HF in childhood. It will focus on the 2014 International Society of Heart and Lung Transplantation (ISHLT), guidelines. These improve the previous 2004 ISHLT guidelines and amalgamate scientific data from the 2013 ACCF/AHA for management of HF in adults. We will focus on the areas of diagnosis and variety in treatment strategies.